Literature DB >> 1835325

Comparison of antibody response by use of synthetic adjuvant system and Freund complete adjuvant in rabbits.

F M Mallon1, M E Graichen, B R Conway, M S Landi, H C Hughes.   

Abstract

Two commercially available synthetic adjuvant systems, trehalose dimycolate (TDM) and TDM + monophosphoryl lipid A (MPL), were compared with Freund complete adjuvant (FCA) for the ability to stimulate antibody production in New Zealand White rabbits (Oryctolagus cuniculus). In addition, each animal was evaluated for adverse reactions. The antigen, rat liver microsomal epoxide hydrolase, was administered SC emulsified with FCA, TDM, or TDM + MPL. Serum antibody titers were stimulated with all 3 adjuvant-antigen combinations. The highest titer was produced by use of FCA; TDM + MPL produced an intermediate response, and TDM produced the lowest titer. All of the rabbits immunized with FCA developed sterile subcutaneous abscesses. Rabbits immunized with TDM or TDM + MPL developed no abscesses, and only slight reactions at the injection site. The synthetic adjuvant system TDM + MPL is recommended for use in rabbits, considering its adequate stimulation of antibody production with minimal adverse reactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835325

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

1.  Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge.

Authors:  William G Fusco; Galyna Afonina; Igor Nepluev; Deborah M Cholon; Neelima Choudhary; Patricia A Routh; Glenn W Almond; Paul E Orndorff; Herman Staats; Marcia M Hobbs; Isabelle Leduc; Christopher Elkins
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

2.  Antibody production in rabbits administered Freund's complete adjuvant and carprofen concurrently.

Authors:  Joanna E Fishback; Sabrina M Stronsky; Catherine A Green; Krystal D Bean; Jeffrey W Froude
Journal:  Lab Anim (NY)       Date:  2016-02       Impact factor: 12.625

3.  A vaccine of L2 epitope repeats fused with a modified IgG1 Fc induced cross-neutralizing antibodies and protective immunity against divergent human papillomavirus types.

Authors:  Xue Chen; Hongyang Liu; Ting Zhang; Yanchun Liu; Xixiu Xie; Zhirong Wang; Xuemei Xu
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

4.  A CFA-Induced Model of Inflammatory Skin Disease in Miniature Swine.

Authors:  Nalú Navarro-Alvarez; Beatriz M M Gonçalves; Alec R Andrews; David H Sachs; Christene A Huang
Journal:  Int J Inflam       Date:  2018-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.